SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Scope & Guideline

Pioneering knowledge in neurology and seizures.

Introduction

Welcome to the SEIZURE-EUROPEAN JOURNAL OF EPILEPSY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1059-1311
PublisherW B SAUNDERS CO LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1992 to 2024
AbbreviationSEIZURE-EUR J EPILEP / Seizure
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND

Aims and Scopes

The Seizure-European Journal of Epilepsy focuses on advancing the understanding of epilepsy through a multidisciplinary approach that encompasses clinical research, genetics, neurophysiology, and treatment options. The journal aims to provide a platform for sharing significant findings that can contribute to improved diagnosis, management, and quality of life for individuals affected by epilepsy.
  1. Clinical Research on Epilepsy:
    The journal publishes studies that explore clinical aspects of epilepsy, including treatment efficacy, patient outcomes, and management strategies across different populations.
  2. Genetic and Molecular Studies:
    There is a strong emphasis on research related to genetic factors associated with epilepsy, including genotype-phenotype correlations and novel gene discoveries that contribute to understanding the underlying mechanisms of epileptic disorders.
  3. Neurophysiology and Imaging Techniques:
    Papers often utilize advanced neuroimaging and electrophysiological techniques to investigate brain activity related to seizures, enhancing the understanding of epileptic networks and their dynamics.
  4. Public Health and Epidemiology:
    The journal also addresses public health issues related to epilepsy, including epidemiological studies on incidence, prevalence, and mortality rates, as well as the socio-economic impact of the condition.
  5. Interdisciplinary Approaches:
    The journal encourages interdisciplinary research that integrates insights from neurology, psychiatry, genetics, and public health to provide a holistic view of epilepsy and its management.
The journal is increasingly reflecting current trends in epilepsy research, particularly in areas that address the complexities of the condition and its management. These emerging themes highlight the evolving landscape of epilepsy studies and the pressing need for innovative approaches.
  1. Precision Medicine and Genetic Testing:
    There is a growing focus on personalized medicine approaches, including the use of genetic testing to guide treatment decisions and understand individual patient responses to therapy.
  2. Neuroinflammation and Immune Mechanisms:
    Research on the role of neuroinflammatory processes in epilepsy is gaining traction, with studies investigating how systemic inflammation may influence seizure activity and treatment responses.
  3. Digital Health and Telemedicine:
    The rise of digital health technologies, including telemedicine and remote monitoring, is becoming a significant area of interest, especially in light of the COVID-19 pandemic and its implications for patient care.
  4. Psychogenic Non-Epileptic Seizures (PNES):
    There is an emerging trend in studying the psychological and social aspects of epilepsy, particularly the differentiation and management of PNES, which are often misdiagnosed.
  5. Quality of Life and Patient-Centered Research:
    An increasing number of studies are focusing on the quality of life for patients with epilepsy, including the psychosocial impacts of the condition and the effectiveness of interventions aimed at improving overall well-being.

Declining or Waning

While the journal has consistently published on a wide array of epilepsy-related topics, certain areas appear to be experiencing a decline in focus. This may reflect shifting research priorities or the maturation of knowledge in these domains.
  1. Traditional Pharmacological Approaches:
    There is a noticeable decrease in studies focusing solely on traditional anti-seizure medications. As new treatments and management strategies emerge, the emphasis has shifted towards comparative effectiveness and personalized medicine.
  2. Basic Science Research:
    Research centered on basic science mechanisms of epilepsy has become less frequent, potentially due to a growing interest in translational studies that directly impact clinical practice.
  3. Generalized Epilepsy Syndromes:
    Papers specifically addressing generalized epilepsy syndromes appear to be waning in favor of more detailed investigations into specific genetic or treatment-resistant forms of epilepsy.
  4. Historical Perspectives:
    The publication of historical analyses and retrospective studies on the evolution of epilepsy treatment has diminished, indicating a shift towards contemporary and future-focused research.
  5. Surgical Interventions:
    While surgical outcomes are still explored, there seems to be less emphasis on traditional surgical techniques, with a growing interest in minimally invasive and novel approaches.

Similar Journals

EPILEPSIA

Pioneering insights for better patient outcomes.
Publisher: WILEYISSN: 0013-9580Frequency: 12 issues/year

EPILEPSIA is a premier academic journal published by Wiley, with a storied history dating back to 1909, making it a cornerstone in the field of epilepsy research and neurology. With an impressive impact factor reflecting its robust contribution to the academic community, EPILEPSIA is categorized in the top quartile (Q1) in both neurology and clinical neurology as of 2023, underscoring its significance and prestige. The journal is ranked #15 out of 192 in Neuroscience & Neurology and #34 out of 400 in Medicine & Neurology (clinical) within Scopus, indicating its essential role in advancing knowledge and treatments related to epilepsy. Researchers and clinicians are encouraged to contribute groundbreaking studies, case reports, and reviews that inform best practices and improve patient outcomes. Although EPILEPSIA currently does not offer open access options, its detailed exploration of both fundamental and clinical aspects of epilepsy ensures wide dissemination of crucial findings among professionals and students alike, furthering the understanding and management of this complex condition.

International Journal of Biomedicine

Empowering discovery at the intersection of health and science.
Publisher: INT MEDICAL RESEARCH & DEVELOPMENT CORPISSN: 2158-0510Frequency: 4 issues/year

International Journal of Biomedicine, published by INT MEDICAL RESEARCH & DEVELOPMENT CORP, is a premier Open Access journal dedicated to advancing knowledge in the multifaceted fields of biomedicine, including but not limited to biochemistry, genetics, immunology, microbiology, and neuroscience. With its ISSN 2158-0510 and E-ISSN 2158-0529, this journal has been serving as a significant platform for researchers since its inception in 2011, ensuring the dissemination of high-quality, peer-reviewed articles. Despite currently holding a Q4 ranking in prominent categories such as Biochemistry, Genetics and Molecular Biology and Neuroscience, the journal plays a vital role in fostering scientific dialogue and innovation in these rapidly evolving domains. The journal's commitment to accessibility further empowers both seasoned professionals and budding scholars to contribute to, and benefit from, the wealth of research that characterizes the biomedicine landscape. With a significant emphasis on interdisciplinary approaches and contemporary issues, the International Journal of Biomedicine is an essential resource for those aiming to navigate the complex intersections of health, disease, and biomedical discovery.

Journal of Pediatric Epilepsy

Innovating solutions for young minds affected by epilepsy.
Publisher: GEORG THIEME VERLAG KGISSN: 2146-457XFrequency: 4 issues/year

The Journal of Pediatric Epilepsy, published by GEORG THIEME VERLAG KG, is a dedicated platform for advancing the understanding and treatment of pediatric epilepsy. With ISSN 2146-457X and E-ISSN 2146-4588, this journal provides vital insights and research findings relevant to clinicians, researchers, and students in the fields of neurology, pediatrics, and psychiatry. Although its coverage in Scopus was discontinued from 2012 to 2015, the journal continues to contribute to the body of knowledge within this critical area by focusing on novel therapeutic strategies, clinical studies, and case reports that address the unique challenges faced by children with epilepsy. The journal is committed to fostering collaboration and innovation in the treatment of pediatric seizure disorders, making it an essential resource for anyone dedicated to improving outcomes in this vulnerable population.

Epilepsi

Bridging knowledge and practice in epilepsy care.
Publisher: KARE PUBLISSN: 1300-7157Frequency: 3 issues/year

Epilepsi is an esteemed academic journal dedicated to advancing the field of epilepsy research and treatment, published by KARE PUBL. With its open access model established since 2017, the journal ensures that vital research findings are easily accessible to a global audience, thereby fostering collaboration and knowledge sharing among researchers, healthcare professionals, and students. The journal focuses on a comprehensive range of topics within neurology, including clinical studies, therapeutic advancements, and innovative approaches to epilepsy management. Located in Istanbul, Turkey, Epilepsi aims to bridge the gap between research and practice, enhancing understanding and patient care for individuals affected by epilepsy. Its commitment to high-quality, peer-reviewed content makes it a significant resource for anyone involved in epilepsy research or clinical practice.

Annals of Indian Academy of Neurology

Advancing Neurological Insights for a Healthier Tomorrow
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-2327Frequency: 4 issues/year

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

Neurologia i Neurochirurgia Polska

Enhancing Knowledge, Enriching Lives
Publisher: VIA MEDICAISSN: 0028-3843Frequency: 6 issues/year

Neurologia i Neurochirurgia Polska is a prestigious Polish journal dedicated to advancements in the fields of neurology and neurosurgery, published by VIA MEDICA. With a rich history dating back to 1967, this journal serves as a critical platform for disseminating significant research findings and clinical practices that advance our understanding of neurological disorders and surgical interventions. Registered under ISSN 0028-3843 and E-ISSN 1897-4260, it boasts commendable rankings as reflected in its 2023 categorical quartiles: Q3 in Neurology (Clinical) and Q2 in Surgery, indicating its substantial impact within these domains. Furthermore, its Scopus rankings reveal that it is positioned at Rank #125/551 within Medicine-Surgery and Rank #187/400 in Medicine-Neurology (Clinical), showcasing its importance in academic and clinical circles. Although not currently open access, the journal remains accessible to readers and practitioners who seek to stay updated on innovative research and methodologies. The journal’s objective is to foster knowledge exchange and stimulate scientific dialogue among researchers, professionals, and students, thus shaping the future of neurology and neurosurgery in Poland and beyond. Located at UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND, it invites contributions that inspire and elevate the standards of medical practice.

Stroke Research and Treatment

Exploring innovative solutions for neurological disorders.
Publisher: HINDAWI LTDISSN: 2090-8105Frequency: 1 issue/year

Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.

South Asian Journal of Cancer

Illuminating breakthroughs in oncology and prevention.
Publisher: GEORG THIEME VERLAG KGISSN: 2278-330XFrequency: 4 issues/year

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.

Erciyes Medical Journal

Elevating medical discourse for the global community.
Publisher: ERCIYES UNIV SCH MEDICINEISSN: 2149-2247Frequency: 6 issues/year

Welcome to the Erciyes Medical Journal, a distinguished publication from the Erciyes University School of Medicine that has been dedicated to advancing the field of medical science since its establishment. This Open Access journal, available in both print (ISSN: 2149-2247) and online (E-ISSN: 2149-2549), offers researchers unparalleled access to cutting-edge research and medical advancements. Following its transition to open access in 2018, the journal aims to democratize knowledge, allowing healthcare professionals, researchers, and students alike to engage with high-quality content that is both accessible and impactful. Although its coverage in databases such as Scopus has been discontinued since 2018, the Erciyes Medical Journal continues to foster scholarly dialogue and innovation in medicine, addressing critical health issues relevant to the global community. As a hub for knowledge exchange, this journal not only publishes original research articles but also encourages the submission of reviews, case studies, and clinical practice articles, thereby facilitating a comprehensive understanding of medical challenges and breakthroughs.

Epilepsia Open

Innovating clinical practices for epilepsy management.
Publisher: WILEYISSN: Frequency: 4 issues/year

Epilepsia Open is a premier open access journal dedicated to advancing the field of neurology, particularly in the area of epilepsy research and clinical practice. Published by WILEY since 2016, this journal aims to provide a platform for high-quality, peer-reviewed research that fosters collaboration among researchers, clinicians, and educators within the global neurological community. With an impactful presence in the field, it holds a prestigious Q2 ranking in both Neurology and Clinical Neurology categories as of 2023 and has been recognized for its contributions to the understanding of epilepsy through its diverse range of articles, reviews, and clinical studies. Researchers and practitioners can benefit from the journal's open access model, which ensures that valuable findings are readily available to the public, promoting further developments in treatment and care. The journal's significant visibility is reflected in its Scopus rankings, where it ranks in the top half of peer-reviewed journals in both Neurology and Neuroscience categories. For those committed to improving the lives of those affected by epilepsy, Epilepsia Open represents a crucial resource for cutting-edge knowledge and innovative practices.